AMICUS THERAPEUTICS, INC. — Director's Dealing 2018

Jan 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-01-02

Reporting Person: RAAB MICHAEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-02	Common Stock	M	9366	$15.00	Acquired	15180	Direct
2018-01-02	Common Stock	S	9366	$15.00	Disposed	5814	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-02	Stock Options (right to buy)	$2.81	M	5000	Disposed	2020-06-15	Common Stock (5000)	Direct
2018-01-02	Stock Options (right to buy)	$7.51	M	4366	Disposed	2021-05-24	Common Stock (4366)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

F2: This price of $15.00 is the sole purchase price for the transactions reported on this line.

F3: This price of $15.00 is the sole sale price for the transactions reported on this line.